Document Detail


Diffuse bone marrow uptake on F-18 FDG PET in patients with myelodysplastic syndromes.
MedLine Citation:
PMID:  17053396     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
It is well known that hematopoietic cytokine stimulation can cause diffuse increase of FDG accumulation in bone marrow on PET imaging, which simulates that seen in patients with bone marrow metastases. However, diffuse bone marrow FDG uptake can be caused by other etiologies. We report 2 patients who did not have a history of hematopoietic cytokine stimulation. The FDG PET images showed diffuse bone marrow FDG uptake, and the patients were diagnosed as having myelodysplastic syndromes. These cases demonstrate that diffuse FDG uptake by bone marrow can suggest neoplastic disease of the hematopoietic tissues.
Authors:
Kentaro Inoue; Ken Okada; Hideo Harigae; Yasuyuki Taki; Ryoi Goto; Shigeo Kinomura; Shunsuke Kato; Tomohiro Kaneta; Hiroshi Fukuda
Related Documents :
114016 - Osteogenic sarcoma after retinoblastoma radiotherapy.
23759516 - Which fdg/pet parameters of the primary tumors in colon or sigmoid cancer provide the b...
11904686 - The accuracy of imaging in the local staging of appendicular osteosarcoma.
12034946 - Osteomyelitis: diagnosis with (99m)tc-labeled antigranulocyte antibodies compared with ...
19161186 - Added value of breathhold diffusion-weighted mri in detection of small hepatocellular c...
17365236 - Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 t with perfluoroc...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Clinical nuclear medicine     Volume:  31     ISSN:  0363-9762     ISO Abbreviation:  Clin Nucl Med     Publication Date:  2006 Nov 
Date Detail:
Created Date:  2006-10-20     Completed Date:  2007-01-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7611109     Medline TA:  Clin Nucl Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  721-3     Citation Subset:  IM    
Affiliation:
Department of Nuclear Medicine and Radiology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan. kenta@idac.tohoku.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Bone Marrow / metabolism*,  radionuclide imaging*
Bone Marrow Neoplasms / metabolism,  radionuclide imaging
Diagnosis, Differential
Fluorodeoxyglucose F18 / diagnostic use*,  pharmacokinetics*
Humans
Male
Middle Aged
Myelodysplastic Syndromes / metabolism*,  radionuclide imaging*
Positron-Emission Tomography / methods*
Radiopharmaceuticals / diagnostic use,  pharmacokinetics
Tissue Distribution
Chemical
Reg. No./Substance:
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Initial diagnosis and treatment follow up of neuroblastoma invasion of inferior vena cava with I-123...
Next Document:  Attenuation artifact from sclerotic bone can mimic active bone metastasis on PET-CT.